The fixed point in healthcare partnerships.
Northstra Health works across three practice areas: compounding pharmacy programs for physician practices, patient access and growth for clinical research sites, and advisory for owners and buyers of research sites and medical practices.
Contracted with leading U.S. compounding pharmacies
One firm, three ways we work.
Choose a practice area to see what each team does, and the numbers that shape the work.
The right compounding partner for every prescription.
We match practices to contracted 503A and 503B partners by what they prescribe and administer, manage the move away from incumbent pharmacies, and stay on the account after launch.
- 503A and 503B matching
- Formulary transitions
- Onboarding and account management
From patient access to site growth.
Our research teams find patients, win studies, run them well, and grow the investigator network behind each site.
- Patient access and enrollment
- Business development
- Site operations and investigator networks
Selling or buying, with an independent read.
Sell-side preparation, buy-side sourcing, valuation readiness, and operational diligence for clinical research sites and physician practices.
- Sell-side preparation
- Buy-side sourcing
- Valuation readiness and diligence
The introduction is not the deliverable. A working relationship is.How Northstra Health works
Contracted with leading U.S. compounding pharmacies.
We hold contracted partnerships with leading compounding pharmacies across the country, so every practice we work with is matched to a partner that has already been qualified.
- State board licensureActive and in good standing in every state the practice is in.
- USP 795, 797, and 800Non-sterile, sterile, and hazardous compounding standards met.
- FDA registration and inspectionsRegistration and inspection history reviewed for outsourcing facilities.
- Turnaround and shippingDelivery schedules a clinic can plan around.
- Catalog depthCoverage across the categories our practices prescribe.
- Written agreementsEvery partnership documented and compliance-reviewed.
The numbers behind each practice area.
Two signals from each market we work in, drawn from federal data and published research.
Sterile compounding share of the 503B market
Sterile products make up most of what outsourcing facilities supply.
Coherent Market Insights, 2026Outsourcing facilities still registered
Of 71 facilities registered with the FDA in 2014, 20 remained registered in 2022.
KPMG analysis of FDA dataHow sites perform against enrollment targets
Almost half of the sites selected for a trial enroll no one or fall short.
Tufts CSDDWhat an idle site costs
A 30-month study at a site that enrolls a single patient.
PhesiPhysicians employed by hospitals or corporations
More than four in five U.S. physicians no longer practice independently.
PAI and Avalere, 2026Practice acquisitions, 2024 and 2025
Private equity, insurers, and other corporate buyers now acquire more practices than hospitals.
PAI and AvalereHow an engagement runs.
The same four stages whether the client is a practice, a pharmacy, a research site, or a buyer.
Assess
A direct read on what the client runs today. If the fit is not there, we say so first.
Match
Partners shortlisted on catalog, facility type, therapeutic area, geography, and service.
Introduce
Warm introductions with the context both sides need to start from specifics.
Stay involved
We remain in the relationship through onboarding, first orders, first patients, or close.
Three practice areas, six teams.
Every engagement is led by a core team from its practice area and staffed from specialists across the firm. Join our team
The pharmacy team
- Pharmacy partnerships
- Practice matching, formulary transitions, onboarding, and account management for practices and pharmacy partners.
The clinical research teams
- Patient access and enrollment
- Recruitment strategy, community outreach, referral networks, and pre-screening.
- Business development
- Sponsor and CRO relationships, feasibility responses, and study pipeline.
- Site operations
- Startup, staffing, SOPs, and inspection readiness.
- Investigator networks
- Principal and sub-investigator sourcing and embedded site models.
The advisory team
- Transactions
- Sell-side preparation for sites and practices, buy-side sourcing, valuation readiness, and operational diligence.
Where we stand.
Points of view from across our pharmacy, clinical research, and advisory work.
The compounding decision most practices get wrong.
Routing is the decision that matters: patient-specific prescriptions belong at a 503A pharmacy, office-use stock at a 503B outsourcing facility. Many practices need both and find out only after onboarding stalls.
Enrollment is a community problem before it is a marketing problem.
Very few physicians and nurses ever refer a patient to a trial. Sites that enroll well build referral relationships with the practices their patients already trust.
What an enrollment number hides in diligence.
A network's enrollment often rests on a small group of high-performing sites and investigators. Diligence has to find out who is actually producing and whether they stay after close.
Engaged nationwide.
We support practices, pharmacies, research sites, and owners wherever they operate.
Before the first call.
What practices, pharmacies, research sites, and owners ask most often.
Pharmacy: What is the difference between a 503A pharmacy and a 503B outsourcing facility?
A 503A pharmacy fills patient-specific prescriptions, one patient and one order at a time. A 503B outsourcing facility manufactures under cGMP and supplies office-use stock in bulk with no patient name attached. Many practices need both.
Pharmacy: Do you work with a single pharmacy?
No. We hold contracted relationships with multiple pharmacy partners and route each practice by category and prescribing profile.
Clinical research: Can you help our site enroll faster?
Yes. Our patient access and enrollment team builds recruitment around the community a site serves, from outreach and referral networks to pre-screening, tied to the studies the site is running.
Clinical research: Do you help sites win new studies?
Yes. Our business development team positions sites with sponsors and CROs, supports feasibility responses, and builds a pipeline that fits the site's patients and investigators.
Advisory: We are thinking about selling. When should we call?
Before the first buyer conversation. The terms of a sale are shaped by how the operating data is organized and presented long before a letter of intent arrives.
Tell us where we can help.
Pharmacy, clinical research, or advisory. Every engagement begins with a conversation about what you run today.